Bendamustine for the treatment of indolent (low grade) non-Hodgkin's lymphoma that is refractory to rituximab (terminated appraisal)

Technology appraisal
Reference number: TA206
Published: 27 October 2010

NICE publishes guidance on three cancer drugs

2010/153 NICE publishes guidance on three cancer drugs

2010/153 NICE publishes guidance on three cancer drugs

2010/153 NICE publishes guidance on three cancer drugs
27 October 2010
(72.97 Kb 21 sec @ 28.8Kbps)

Adobe Acrobat reader required.

Adobe Acrobat reader required.